Italian Physicians’ Opinions on Rotavirus Vaccine Implementation

Rotavirus (RV) infection is the main cause of severe acute gastroenteritis (GE) in the pediatric population and has a major impact in both developing and industrialized countries. The reduction of severe RVGE cases, followed by death or hospitalization, is considered the main benefit of RV vaccinati...

Full description

Bibliographic Details
Main Authors: Valentin Mita, Michele Arigliani, Laura Zaratti, Raffaele Arigliani, Elisabetta Franco
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/6/4/56
id doaj-c80661f18a514d8ebe69a8fb9eec7d30
record_format Article
spelling doaj-c80661f18a514d8ebe69a8fb9eec7d302020-11-24T22:52:29ZengMDPI AGPathogens2076-08172017-11-01645610.3390/pathogens6040056pathogens6040056Italian Physicians’ Opinions on Rotavirus Vaccine ImplementationValentin Mita0Michele Arigliani1Laura Zaratti2Raffaele Arigliani3Elisabetta Franco4Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, ItalyDepartment of Clinical and Experimental Medical Sciences, University Hospital of Udine, 33100 Udine, ItalyDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, ItalyDepartment of Pediatrics, Università Politecnica delle Marche, 60126 Ancona, ItalyDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, ItalyRotavirus (RV) infection is the main cause of severe acute gastroenteritis (GE) in the pediatric population and has a major impact in both developing and industrialized countries. The reduction of severe RVGE cases, followed by death or hospitalization, is considered the main benefit of RV vaccination, even though its implementation often faces obstacles. In Italy, the recently approved National Immunization Plan aims to overcome the differences among regions, offering a universal free RV vaccination. The aim of the study was to evaluate the opinions on benefit and acceptability of RV vaccination related to the perception of the burden of RV disease. Data were collected from 108 physicians in 2015 by a questionnaire consisting of 12 questions; some answers were compared with those obtained with a similar tool in 2011. The majority of respondents (76.2%) was convinced of the benefit of the vaccine and 57.4% recommended it routinely, but more than half indicated a <25% adherence to RV vaccination among their patients. As the main reasons of vaccine refusal, skepticism about the vaccine (60.4%) and its cost (34.1%) were indicated. Our data confirm that more information and counselling are needed to increase RV vaccine coverage.https://www.mdpi.com/2076-0817/6/4/56rotavirusnew vaccinesimmunizationcoveragephysiciansknowledgeattitudesbeliefsintentions
collection DOAJ
language English
format Article
sources DOAJ
author Valentin Mita
Michele Arigliani
Laura Zaratti
Raffaele Arigliani
Elisabetta Franco
spellingShingle Valentin Mita
Michele Arigliani
Laura Zaratti
Raffaele Arigliani
Elisabetta Franco
Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
Pathogens
rotavirus
new vaccines
immunization
coverage
physicians
knowledge
attitudes
beliefs
intentions
author_facet Valentin Mita
Michele Arigliani
Laura Zaratti
Raffaele Arigliani
Elisabetta Franco
author_sort Valentin Mita
title Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
title_short Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
title_full Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
title_fullStr Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
title_full_unstemmed Italian Physicians’ Opinions on Rotavirus Vaccine Implementation
title_sort italian physicians’ opinions on rotavirus vaccine implementation
publisher MDPI AG
series Pathogens
issn 2076-0817
publishDate 2017-11-01
description Rotavirus (RV) infection is the main cause of severe acute gastroenteritis (GE) in the pediatric population and has a major impact in both developing and industrialized countries. The reduction of severe RVGE cases, followed by death or hospitalization, is considered the main benefit of RV vaccination, even though its implementation often faces obstacles. In Italy, the recently approved National Immunization Plan aims to overcome the differences among regions, offering a universal free RV vaccination. The aim of the study was to evaluate the opinions on benefit and acceptability of RV vaccination related to the perception of the burden of RV disease. Data were collected from 108 physicians in 2015 by a questionnaire consisting of 12 questions; some answers were compared with those obtained with a similar tool in 2011. The majority of respondents (76.2%) was convinced of the benefit of the vaccine and 57.4% recommended it routinely, but more than half indicated a <25% adherence to RV vaccination among their patients. As the main reasons of vaccine refusal, skepticism about the vaccine (60.4%) and its cost (34.1%) were indicated. Our data confirm that more information and counselling are needed to increase RV vaccine coverage.
topic rotavirus
new vaccines
immunization
coverage
physicians
knowledge
attitudes
beliefs
intentions
url https://www.mdpi.com/2076-0817/6/4/56
work_keys_str_mv AT valentinmita italianphysiciansopinionsonrotavirusvaccineimplementation
AT michelearigliani italianphysiciansopinionsonrotavirusvaccineimplementation
AT laurazaratti italianphysiciansopinionsonrotavirusvaccineimplementation
AT raffaelearigliani italianphysiciansopinionsonrotavirusvaccineimplementation
AT elisabettafranco italianphysiciansopinionsonrotavirusvaccineimplementation
_version_ 1725665854321852416